Orchid Chemicals & Pharmaceuticals has informed that the Allotment Committee of the Board of Directors at their meeting held on October 09, 2015 has allotted 3,702,450 equity shares of Rs 10 each at a price of Rs 49.79 (Including a premium of Rs 39.79 per share) as the second and final tranche to the Promoter group Company Orchid Healthcare Private Limited on Preferential Basis as per the Corporate Debt Restructuring (CDR) Scheme approved by the CDR Empowered Group in terms of CDR Scheme.
The above information is a part of company’s filings submitted to BSE.
